Boston Scientific Corporation (BSX)

Market Cap	145.69B
Revenue (ttm)	16.75B
Net Income (ttm)	1.85B
Shares Out	1.48B
EPS (ttm)	1.25
PE Ratio	78.80
Forward PE	34.42
Dividend	n/a
Ex-Dividend Date	n/a

Volume	10,995,280
Open	96.94
Previous Close	100.05
Day's Range	96.65 - 99.86
52-Week Range	66.80 - 107.17
Beta	0.73
Analysts	Strong Buy
Price Target	107.23 (+8.86%)
Earnings Date	Apr 23, 2025

About BSX

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates in two segments, MedSurg and Cardiovascular. The company offers devices to diagnose and treat a range of gastrointestinal conditions, such as resolution clips, biliary stent systems, stents and electrocautery enhanced delivery systems, direct visualization systems, digital catheters, and single-use duodenoscopes, as well as endoluminal surgery and infection prevention portfolios; devices ...

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: May 18, 1992
• Employees: 53,000
• Stock Exchange: NYSE
• Ticker Symbol: BSX
• Website: https://www.bostonscientific.com

Financial Performance

In 2024, Boston Scientific's revenue was $16.75 billion, an increase of 17.61% compared to the previous year's $14.24 billion. Earnings were $1.85 billion, an increase of 18.03%.

Analyst Forecast

According to 23 analysts, the average rating for BSX stock is "Strong Buy." The 12-month stock price forecast is $107.23, which is an increase of 8.86% from the latest price.

Price Target

$107.23

(8.86% upside)

Analyst Consensus: Strong Buy